SIA
GILD icon

SGL Investment Advisors’s Gilead Sciences GILD Stock Holding History

SGL Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$364K Buy
2,734
+144
+6% +$19K 0.13% 116
2026
Q1 		$346K Buy
2,590
+208
+9% +$29.1K 0.13% 108
2025
Q4 		$356K Buy
2,382
+276
+13% +$33.5K 0.14% 108
2025
Q3 		$257K Buy
+2,106
New +$239K 0.11% 114

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SGL Investment Advisors's GILD Position: Q2 2026 in Review

SGL Investment Advisors increased its Gilead Sciences (GILD) stake by 5.6% in Q2 2026, buying an estimated $19K and bringing the position to 2,734 shares worth $364K. The position accounts for 0.13% of the portfolio, ranked #116.

SGL Investment Advisors first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • SGL Investment Advisors held 2,734 shares of Gilead Sciences worth $364K as of Q2 2026.
  • SGL Investment Advisors bought 144 Gilead Sciences shares in Q2 2026, an estimated $19K.
  • Gilead Sciences made up 0.13% of SGL Investment Advisors's portfolio in Q2 2026, its #116 holding.
  • SGL Investment Advisors first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on SGL Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.